-
Safety Shot Claps Back At Short Sellers: 'Trying Safety Shot Is Believing In Safety Shot'
Wednesday, November 22, 2023 - 2:29pm | 416Safety Shot Inc (NASDAQ: SHOT) has issued a warning to shareholders following a short report that sparked a selloff in shares Wednesday. What To Know: Safety Shot shares are tumbling Wednesday following a short report from Capybara Research. The short seller makes claims...
-
Jupiter Wellness Retires Approximately 10% Of Its Outstanding Shares
Friday, June 17, 2022 - 9:52am | 364Jupiter Wellness, Inc. (NASDAQ: JUPW) purchased and retired 2,43 million common shares, which reduces the company's outstanding common shares to 22.15 million an approximate 10% reduction in shares outstanding. The company has a $5.0 million share buyback program. Under the program, shares of...
-
Jupiter Wellness To Offer Clinical Research Services With Acquisition Of Ascent Clinical Research
Wednesday, April 27, 2022 - 1:58pm | 258Jupiter Wellness, Inc. (NASDAQ: JUPW) has concluded an asset purchase agreement with Ascent Clinical Research, Inc. through which it has acquired certain clinical assets including clinical trial research contracts worth $3 million in annual revenues for a purchase price of 5% royalties on future...
-
Jupiter Wellness To Dividend SRM Entertainment Subsidiary To Its Stockholders
Monday, January 24, 2022 - 3:26pm | 417Jupiter Wellness, Inc. (NASDAQ: JUPW) revealed plans Monday to dividend its wholly-owned subsidiary, SRM Entertainment to its stockholders with Jupiter’s merger with Next Frontier Pharmaceuticals, Inc. Each Jupiter Wellness stockholder will be entitled to approximately one share of...
-
Jupiter Wellness & Next Frontier Pharmaceuticals Merge, Will Expand Cannabinoid & Psychedelics Drug Development
Thursday, December 9, 2021 - 2:55pm | 547Jupiter Wellness, Inc. (NASDAQ: JUPW) announced Thursday that it is acquiring Next Frontier Pharmaceuticals, Inc., through a merger with a subsidiary of Jupiter Wellness. Deal Details Under the terms of the agreement, Next Frontier Pharmaceuticals' stockholders will receive convertible...